Renovaro Biosciences (RENB) Q1 2022 Earnings

13MayExpected
Q2 2021
Q3 2021
Q4 2021
Q1 2022
-0.36
-0.28
-0.2
-0.12

Details

Expected EPS
N/A
Actual EPS
-0.12
Surprise EPS
-0.12
Surprise Percent
+∞%

Description

Renovaro Biosciences (RENB) has reported earnings of -0.12 per share for Q1 2022.

0 Comments

Share your thoughts